---
figid: PMC7952883__fonc-11-627229-g003
figlink: pmc/articles/PMC7952883/figure/f3/
number: F3
caption: 'General mechanisms of sildenafil in different types of cancer. The different
  types of cancer are highlighted in colors. Breast cancer (light blue). Three mechanisms
  may decrease tumor progression: Combined therapy sildenafil + DOX, estrogen reduction
  by aromatase blockage or decrease secretion of CXCL16 in fibroblasts with sildenafil
  or tadalafil. Tadalafil can block tumor growth and promote apoptosis. The same effect
  is caused by combined therapy sildenafil + sulindac sulfide through PKG activation.
  Sildenafil can promote PKD2 degradation and decrease proliferation and viability,
  and enhance antitumoral effects of cisplatin. Leukemia (dark green). Sildenafil
  + EGCG promote activity of acid sphingomyelinase increasing apoptosis. Lung cancer
  (light green). Sildenafil may decrease tumor growth through cGMP and enhance cytotoxicity
  of carboplatin to promote apoptosis. Combined therapy of sildenafil + radiotherapy
  reduces activity of MSCS and promotes immune response of CD8+T cells. Colon cancer
  (yellow). Sildenafil prevents inflammation of intestinal epithelium decreasing the
  risk of cancer. Combined therapy sildenafil + curcumin, enhance efficacy of 5-fluorouracil
  to promote apoptosis. Combination of neratinib, regorafenib and sildenafil affects
  mutant KRAS expression to increase sensitivity of cancer cells to immunotherapies
  through MHCA. Prostate cancer (orange). Blocking ABC transporters. Sildenafil disrupted
  the efflux of chemotherapeutics promoting their activity. Sildenafil can promote
  caspase activity and ROS to produce apoptosis and sensitize hypoxic cancer cells
  to chemotherapeutics through NO/cGMP pathway restoring. Brain cancer (deep blue).
  Sildenafil + DOX, improves survival of cancer patients.'
pmcid: PMC7952883
papertitle: 'New Approaches in Oncology for Repositioning Drugs: The Case of PDE5
  Inhibitor Sildenafil.'
reftext: Marian Cruz-Burgos, et al. Front Oncol. 2021;11:627229.
pmc_ranked_result_index: '17069'
pathway_score: 0.9170388
filename: fonc-11-627229-g003.jpg
figtitle: General mechanisms of sildenafil in different types of cancer
year: '2021'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7952883__fonc-11-627229-g003.html
  '@type': Dataset
  description: 'General mechanisms of sildenafil in different types of cancer. The
    different types of cancer are highlighted in colors. Breast cancer (light blue).
    Three mechanisms may decrease tumor progression: Combined therapy sildenafil +
    DOX, estrogen reduction by aromatase blockage or decrease secretion of CXCL16
    in fibroblasts with sildenafil or tadalafil. Tadalafil can block tumor growth
    and promote apoptosis. The same effect is caused by combined therapy sildenafil
    + sulindac sulfide through PKG activation. Sildenafil can promote PKD2 degradation
    and decrease proliferation and viability, and enhance antitumoral effects of cisplatin.
    Leukemia (dark green). Sildenafil + EGCG promote activity of acid sphingomyelinase
    increasing apoptosis. Lung cancer (light green). Sildenafil may decrease tumor
    growth through cGMP and enhance cytotoxicity of carboplatin to promote apoptosis.
    Combined therapy of sildenafil + radiotherapy reduces activity of MSCS and promotes
    immune response of CD8+T cells. Colon cancer (yellow). Sildenafil prevents inflammation
    of intestinal epithelium decreasing the risk of cancer. Combined therapy sildenafil
    + curcumin, enhance efficacy of 5-fluorouracil to promote apoptosis. Combination
    of neratinib, regorafenib and sildenafil affects mutant KRAS expression to increase
    sensitivity of cancer cells to immunotherapies through MHCA. Prostate cancer (orange).
    Blocking ABC transporters. Sildenafil disrupted the efflux of chemotherapeutics
    promoting their activity. Sildenafil can promote caspase activity and ROS to produce
    apoptosis and sensitize hypoxic cancer cells to chemotherapeutics through NO/cGMP
    pathway restoring. Brain cancer (deep blue). Sildenafil + DOX, improves survival
    of cancer patients.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MTOR
  - CD274
  - KRAS
  - ARG1
  - CASP1
  - CASP2
  - CASP8
  - CASP9
  - CASP14
  - CASP12
  - CASP3
  - CASP4
  - CASP5
  - CASP6
  - CASP7
  - CASP10
  - ABCG2
  - ABCC1
  - ABCB1
  - HSP90B1
  - TRAP1
  - HSP90AB1
  - CTNNB1
  - PRKG1
  - PKD2
  - 5-fluorouracil
  - Neratinib
  - Regarafenib
  - Curcumin
  - 'NO'
  - CGMP
  - Carboplatin
  - EGCG
  - DOX
  - Sulindac
  - Sulfide
  - Cisplatin
  - Tadalafil
  - Androgens
  - cancer
  - Cytotoxicity
genes:
- word: MTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: PDL-1
  symbol: PDL1
  source: hgnc_alias_symbol
  hgnc_symbol: CD274
  entrez: '29126'
- word: KRAS
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: ARG1
  symbol: ARG1
  source: hgnc_symbol
  hgnc_symbol: ARG1
  entrez: '383'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP1
  entrez: '834'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP2
  entrez: '835'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP8
  entrez: '841'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP9
  entrez: '842'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP14
  entrez: '23581'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP12
  entrez: '100506742'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP3
  entrez: '836'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP4
  entrez: '837'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP5
  entrez: '838'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP6
  entrez: '839'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP7
  entrez: '840'
- word: Caspase
  symbol: Caspase
  source: bioentities_symbol
  hgnc_symbol: CASP10
  entrez: '843'
- word: ABCG2
  symbol: ABCG2
  source: hgnc_symbol
  hgnc_symbol: ABCG2
  entrez: '9429'
- word: ABCC1
  symbol: ABCC1
  source: hgnc_symbol
  hgnc_symbol: ABCC1
  entrez: '4363'
- word: -ABCC1
  symbol: ABCC1
  source: hgnc_symbol
  hgnc_symbol: ABCC1
  entrez: '4363'
- word: ABCB1
  symbol: ABCB1
  source: hgnc_symbol
  hgnc_symbol: ABCB1
  entrez: '5243'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90B1
  entrez: '7184'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: TRAP1
  entrez: '10131'
- word: HSP90
  symbol: HSP90
  source: bioentities_symbol
  hgnc_symbol: HSP90AB1
  entrez: '3326'
- word: B-catenin
  symbol: BCATENIN
  source: bioentities_symbol
  hgnc_symbol: CTNNB1
  entrez: '1499'
- word: Ð KG
  symbol: PKG
  source: hgnc_alias_symbol
  hgnc_symbol: PRKG1
  entrez: '5592'
- word: PKD2
  symbol: PKD2
  source: hgnc_symbol
  hgnc_symbol: PKD2
  entrez: '5311'
chemicals:
- word: 5-fluorouracil
  source: MESH
  identifier: D005472
- word: Neratinib
  source: MESH
  identifier: C487932
- word: Regarafenib
  source: ''
  identifier: ''
- word: Curcumin
  source: MESH
  identifier: D003474
- word: 'NO'
  source: ''
  identifier: ''
- word: CGMP
  source: MESH
  identifier: C016276
- word: Carboplatin
  source: MESH
  identifier: D016190
- word: EGCG
  source: MESH
  identifier: C045651
- word: DOX
  source: MESH
  identifier: D004317
- word: Sulindac
  source: MESH
  identifier: D013467
- word: Sulfide
  source: MESH
  identifier: D013440
- word: Cisplatin
  source: MESH
  identifier: D002945
- word: Tadalafil
  source: MESH
  identifier: C429886
- word: Androgens
  source: MESH
  identifier: D000728
diseases:
- word: cancer
  source: MESH
  identifier: D009369
- word: Cytotoxicity
  source: MESH
  identifier: D064420
figid_alias: PMC7952883__F3
redirect_from: /figures/PMC7952883__F3
figtype: Figure
---
